Gold(I) complexes of the type [AuL{κC-2-C6H4P(S)Ph2}] [L = PTA, PPh3, PPh2(C6H4-3-SO3Na) and PPh2(2-py)]: Synthesis, characterisation, crystal structures, and In Vitro and In Vivo anticancer properties
- 30 October 2024
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 281, 117007
Abstract
No abstract availableKeywords
Funding Information
- Australia-India Strategic Research Fund
This publication has 57 references indexed in Scilit:
- Cisplatin Resistance in Cancer Therapy: Causes and Overcoming StrategiesChemistrySelect, 2024
- Potent Anticancer Activity of a Dinuclear Gold(I) bis‐N‐Heterocyclic Imine Complex Related to Thioredoxin Reductase Inhibition in VitroChempluschem, 2023
- Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery SystemsAngewandte Chemie International Edition, 2023
- New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insightsBioMetals, 2020
- Tumor angiogenesis: causes, consequences, challenges and opportunitiesCellular and Molecular Life Sciences, 2019
- Potent and Selective Cytotoxic and Anti‐inflammatory Gold(III) Compounds Containing Cyclometalated Phosphine Sulfide LigandsChemistry – A European Journal, 2019
- Reactivity of Auranofin with Selenols and Thiols – Implications for the Anticancer Activity of Gold(I) CompoundsEuropean Journal of Inorganic Chemistry, 2013
- Gold(I) Complexes of P,N Ligands and Their Catalytic ActivityEuropean Journal of Inorganic Chemistry, 2010
- ( Meta ‐ Sulfonatophenyl) Diphenylphosphine, Sodium Salt and its Complexes with Rhodium(I), Ruthenium(II), Iridium(I)1998
- (Tetrahydrothiophene)Gold(I) or Gold(III) Complexes1989